Hung-Yun. Lin, et.al., Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor., Diabetes, 2005, 54

http://rdf.ncbi.nlm.nih.gov/pubmed/15919793

Hung-Yun. Lin, et.al., Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor., Diabetes, 2005, 54

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating glucose level_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0005559I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• increased triglyceride level_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0005317I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• decreased circulating testosterone level_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0002780I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• increased circulating leptin level_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0005669I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• increased circulating triglyceride level_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0001552I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• decreased adiponectin level_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0004893I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• increased renal fat pad weight_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0009302I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• abnormal fat cell morphology_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0009115I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• increased susceptibility to weight gain_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0005455I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• hyperglycemia_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0001559I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• increased liver triglyceride level_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0009355I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• increased gonadal fat pad weight_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0009285I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• increased white adipose tissue amount_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0000008I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• impaired glucose tolerance_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0005293I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• decreased body weight_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0001262I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• insulin resistance_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0005331I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• increased circulating insulin level_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0002079I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc
• testicular atrophy_Ar<tm1Chc>/Y,Tmem163<Tg(ACTB-cre)2Mrt>/0
  http://metadb.riken.jp/0003205I129SSvEvC57BL6JFVBNArtm1ChcYTmem163TgACTBcre2Mrt0Tmem163TgACTBcre2MrtArtm1Chc